` CGS (CogState Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

CGS
vs
S&P/ASX 300

Over the past 12 months, CGS has outperformed S&P/ASX 300, delivering a return of 25% compared to the S&P/ASX 300's 10% growth.

Stocks Performance
CGS vs S&P/ASX 300

Loading
CGS
S&P/ASX 300
Add Stock
www.alphaspread.com

Performance Gap
CGS vs S&P/ASX 300

Loading
CGS
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
CGS vs S&P/ASX 300

Loading
CGS
S&P/ASX 300
Add Stock

Competitors Performance
CogState Ltd vs Peers

S&P/ASX 300
CGS
VEEV
PME
DOCS
2413
Add Stock

CogState Ltd
Glance View

Market Cap
239.8m AUD
Industry
Health Care

Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

CGS Intrinsic Value
1.728 AUD
Undervaluation 19%
Intrinsic Value
Price
Back to Top